The FIN newsletter is back!

We are so pleased to bring back our Fabry International Network newsletter. We plan to make this a regular publication and would love to include news from your organisation that others in the network would find interesting. This newsletter features the 4th Fabry Expert Meeting in Japan which was described as a huge success, as well as updates … Continue reading “The FIN newsletter is back!”

Read More

Amicus Therapeutics Announces European Commission Approval for Galafold™ (Migalastat) in Patients with Fabry Disease in European Union

Amicus – Launch has Begun in Germany – Broad Label for All Fabry Patients with an Amenable Genetic Mutation First Precision Medicine Approved for Fabry Disease Click here

Read More

April 2015

Please download our April Newsletter here

Read More

December 2014

Please download our December Newsletter here

Read More

September 2014

Please download our September Newsletter here

Read More
Subscribe to News

Subscribe to Our Newsletter